About this trial
The goal of this clinical trial is to learn if morphine added to the spinal anaesthesia can improve postoperative pain treatment for patients undergoing caesarean section, without increasing the risk of serious adverse events in mother and baby.
The main questions it aims to answer are:
* Is the treatment effective in preventing postoperative pain? * Is the treatment safe for both mother and baby?
Participants will be given a normal spinal anaesthesia with addition of either morphine or sodium chloride (inactive substance). All participants will receive standard postoperative pain treatment, including morphine tablets as needed. Researchers will collect data from the electronic medical record and ask the participants to fill out questionnaires about pain levels and possible side effects.
Eligibility criteria
Qualifiers
Patients ≥ 18 years
Singleton pregnancy
Scheduled for planned caesarean section performed under spinal anaesthesia
Written informed consent
Disqualifiers
Allergy to or contraindications towards trial medication
Patients planned for postoperative epidural due to expected difficult postoperative pain management
Patients planned for combined spinal-epidural as primary anaesthesia
Inability to understand and read Danish
Trial design
Treatments tested in this trial
- Intrathecal Morphine
- Placebo (Sodium Chloride Injection, 0.9%)
Treatment groups
Sponsors and collaborators
Anne Juul Wikkelsø
Lead sponsor
Zealand University Hospital
Sponsor institution